A citation-based method for searching scientific literature

John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
Times Cited: 389



C Mathieu, H W Rodbard, B Cariou, Y Handelsman, A Philis-Tsimikas, A M Ocampo Francisco, A Rana, B Zinman. Diabetes Obes Metab 2014
Times Cited: 122




List of shared articles



Times cited


Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
Lorraine Lipscombe, Sonia Butalia, Kaberi Dasgupta, Dean T Eurich, Lori MacCallum, Baiju R Shah, Scot Simpson, Peter A Senior. Can J Diabetes 2020
19

Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella, Valeria Pechtner, Antonella Corcos, Agostino Consoli. Diabetes Metab Res Rev 2019
82

A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes.
Irene Romera, Ana Cebrián-Cuenca, Fernando Álvarez-Guisasola, Fernando Gomez-Peralta, Jesús Reviriego. Diabetes Ther 2019
24

THE IMPACT OF GLP-1 RECEPTOR AGONISTS ON PATIENTS WITH DIABETES ON INSULIN THERAPY.
Janelle B Gyorffy, Andrea N Keithler, Jana L Wardian, Lee A Zarzabal, Alexander Rittel, Mark W True. Endocr Pract 2019
2

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito. Diabetes Res Clin Pract 2019
9

Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Guillermo E Umpierrez, Timothy S Bailey, Danielle Carcia, Charles Shaefer, Jay H Shubrook, Neil Skolnik. J Diabetes 2018
8




Pharmacologic Glycemic Management of Type 2 Diabetes in Adults.
Lorraine Lipscombe, Gillian Booth, Sonia Butalia, Kaberi Dasgupta, Dean T Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R Shah, Scot Simpson. Can J Diabetes 2018
88

A practical approach and algorithm for intensifying beyond basal insulin in type 2 diabetes.
Ronald M Goldenberg, Peter Assimakopoulos, Jeremy D Gilbert, Irving S Gottesman, Jean-François Yale. Diabetes Obes Metab 2018
0


Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone.
Jennifer M Trujillo, Michelle Roberts, Terry Dex, Jason Chao, John White, James LaSalle. Diabetes Obes Metab 2018
9


The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.
Sultan Linjawi, Bruce W Bode, Louis B Chaykin, Jean-Pierre Courrèges, Yehuda Handelsman, Lucine M Lehmann, Abhishek Mishra, Richard W Simpson. Diabetes Ther 2017
66


Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Inka Miñambres, Antonio Pérez. Diabetol Metab Syndr 2017
13




Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano. Diabetes Care 2017
58


Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
Sujoy Ghosh, A G Unnikrishnan, Banshi Saboo, Jothydev Kesavadev, S R Aravind, Sarita Bajaj, Rajesh Rajput, Krishna Seshadri, Narsingh Verma, Arvind Gupta,[...]. Diabetes Metab Syndr 2017
1


The Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes.
Erin St Onge, Shannon Miller, Elizabeth Clements, Lindsay Celauro, Ke'la Barnes. J Transl Int Med 2017
3





Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.
L Østergaard, Christian S Frandsen, S Madsbad. Expert Rev Clin Pharmacol 2016
17